1. Novel Dmt-Tic dipeptide analogues as selective delta-opioid receptor antagonists
- Author
-
S. St‐Onge, T. Mischki, William Brown, Page Daniel, Ralf Schmidt, A. McClory, M. Labarre, J. Butterworth, and K. Payza
- Subjects
congenital, hereditary, and neonatal diseases and abnormalities ,medicine.drug_class ,Stereochemistry ,Clinical Biochemistry ,Pharmaceutical Science ,Peptide ,Binding, Competitive ,Biochemistry ,Chemical synthesis ,Piperazines ,δ-opioid receptor ,chemistry.chemical_compound ,Opioid receptor ,Receptors, Opioid, delta ,Tetrahydroisoquinolines ,mental disorders ,Drug Discovery ,Peptide synthesis ,medicine ,Humans ,Molecular Biology ,chemistry.chemical_classification ,Dipeptide ,Chemistry ,Organic Chemistry ,Antagonist ,Dipeptides ,Isoquinolines ,nervous system diseases ,Guanosine 5'-O-(3-Thiotriphosphate) ,Benzamides ,Tyrosine ,Molecular Medicine ,μ-opioid receptor ,human activities - Abstract
A series of Dmt-Tic analogues with substitution on the Tic aromatic ring has been synthesized and evaluated for opioid receptor affinity and activation. Incorporation of large hydrophobic groups at position 7 of Tic did not greatly alter the delta opioid receptor binding affinities of the dipeptides whereas substitution at position 6 substantially diminished their affinity. These modified Dmt-Tic peptides showed binding affinities as low as 2.5 nM with up to 500-fold selectivity for the delta versus mu opioid receptor and proved to be delta receptor antagonists.
- Published
- 2000